Alpine Biomed Corporation (Alpine Biomed) has doubled its manufacturing capacity and expanded its worldwide network by opening a new facility in Vietnam. The company will produce and distribute medical devices for diagnosing gastroesophageal reflux disease (GERD) from its new manufacturing facility located in HoChiMinh city. The new facility is Alpine Biomed’s latest investment to expand its products and capabilities.
In January 2009, the company acquired Stellate Systems Inc. to increase its neurodiagnostics business and boost its presence in the rapidly growing sleep diagnostics market. Since partnering in 2007 with Water Street Healthcare Partners, a leading private equity firm focused exclusively on the health care industry, Alpine Biomed has achieved record sales and revenue growth. It is projected to increase sales as much as 25% in 2009.
“Our new facility in Vietnam is another key component of our strategic plan to become one of the world’s leading specialty diagnostic device companies,” said Alpine Biomed President and CEO John Arnott. “It is a state-of-the-art facility featuring the most advanced technologies that connect our manufacturing centers around the world to provide our customers with the highest-quality devices that diagnose a range of gastrointestinal and neurological disorders.”
Alpine Biomed’s new facility has been registered with the U.S. Food & Drug Administration (FDA). The manufacturing center will export diagnostic devices to customers throughout the world and employ approximately 100 people.
“I am pleased that our new facility has received certification from ISO, the world’s preeminent organization for quality,” said Vietnam General Manager Minh Le. “Every element of our new facility is designed and built to achieve the upmost standards for quality. Our management team and engineers are dedicated to providing our customers and their patients around the world with the highestquality devices in the industry.”